We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Regulatory authorities in several countries are concerned about a prenatal test made by Shenzhen, China-based BGI group that screens for Down syndrome and other genetic conditions. Available in 52 countries, the prenatal test collects DNA of women and fetuses. Read More
Boston Scientific is expanding its thrombectomy device portfolio by purchasing Freemont, Calif.-based Devoro Medical and its promising Wolf platform. Read More
Device and diagnostics manufacturers can expect supply shortages and other problems due to the COVID-19 pandemic throughout the rest of this year and well into next year. Read More
Expert panels in the European Union will be evaluating some high-risk devices for compliance with the EU’s In Vitro Diagnostic Regulation (IVDR) and they are now accepting applications. Read More
Australia’s Therapeutic Goods Administration (TGA) has filed a lawsuit in the Federal Court of Australia against Medtronic Australasia for the alleged unlawful supply of the company’s Infuse bone graft kit, which contains a medicine and other components to stimulate bone growth in patients. Read More
The FDA has released safety reviews of four materials commonly used in implantable medical devices and the effects of the materials on patients over time. Read More
The system “allows simplified delivery of a wide range of allograft and autograft products, including viscous and fibrous materials,” the company says. Read More